Lv1
50 积分 2023-11-15 加入
177a: FIRST-IN-CLASS ORAL TL1A NANOBODY AND LONG-ACTING TL1A/IL-23 BISPECIFIC NANOBODY: NOVEL THERAPIES FOR INFLAMMATORY BOWEL DISEASE
8天前
已关闭
Protein engineering by cell-surface display
14天前
已完结
By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling
14天前
已完结
Antibody Affinity and Stability Maturation by Error-Prone PCR
14天前
已完结
Structural Considerations in Affinity Maturation of Antibody-Based Biotherapeutic Candidates
14天前
已完结
A review of in vitro stochastic and non-stochastic affinity maturation strategies for phage display derived monoclonal antibodies
14天前
已完结
The Fab fragment of anti-IgE Cε2 domain prevents allergic reactions through interacting with IgE-FcεRIα complex on rat mast cells
22天前
已完结
Fabs targeting a Cε2 epitope disassemble IgE-receptor complexes and suppress anaphylaxis
22天前
已完结
The nature and importance of the inter‐ε chain disulfide bonds in human IgE
23天前
已完结
Structural and Functional Insights Into IgE Receptor Interactions and Disruptive Inhibition
29天前
已完结
皖公网安备34019202002308
